Clinical Trial Update: MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for MK-4646-003 in HIV infection, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MK-4646

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infection | Phase 1 | Status: RECRUITING